Yesterday it was reported that the COB, Pres & CEO of Centene (CNC), Michael Neidorff, exercised options to buy 20,000 CNC shares at $28.51 a share, for a total transaction value of $570.2K.
Following Michael Neidorff’s last CNC Buy transaction on December 18, 2018, the stock climbed by 2.4%.
See today’s analyst top recommended stocks >>
Based on Centene’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $18.86 billion and quarterly net profit of $209 million. In comparison, last year the company earned revenue of $16.56 billion and had a net profit of $241 million. The company has a one-year high of $68.64 and a one-year low of $41.62. CNC’s market cap is $31.7B and the company has a P/E ratio of 19.87.
15 different firms, including Barclays and Bernstein, currently also have a Buy rating on the stock. Starting in February 2020, CNC received 7 Buy ratings in a row. One of the top 25 analysts, according to TipRanks.com, recently recommended Buy CNC with a $83.00 price target.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid.
Read More on CNC:
